Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05512143 · ClinicalTrials.gov registry record · NA

TMS for PTSD and Blood Pressure

A NA study of Hypertension and Post Traumatic Stress Disorder, sponsored by Lifespan.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05512143 is a NA study of Hypertension and Post Traumatic Stress Disorder that is active but no longer recruiting, run by Lifespan. The registered enrollment target is 30 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05512143, a NA study of Hypertension and Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by Lifespan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this randomized clinical trial, we will test the short and longer term effects of repetitive transcranial magnetic stimulation (TMS) on blood pressure among reproductive aged female participants with elevated symptoms of post-traumatic stress disorder and hypertension.

Interventions

  • DEVICE Transcranial magnetic stimulation

Study Locations (1)

Rhode Island

  • Lifespan Hospital - Providence

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-02-15
Est. Completion 2028-01-31
Phase NA

Sponsor

Lifespan

18 total trials

What the Registry Record Tells You About NCT05512143

The ClinicalTrials.gov registry entry for NCT05512143 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Lifespan, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Transcranial magnetic stimulation is the first listed.

NCT05512143 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05512143 about?

NCT05512143 is a clinical study titled "TMS for PTSD and Blood Pressure". In this randomized clinical trial, we will test the short and longer term effects of repetitive transcranial magnetic stimulation (TMS) on blood pressure among reproductive aged female participants with elevated symptoms of post-traumatic stress disorder and hypertension.

What is the current status of trial NCT05512143?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-02-15. Estimated completion is 2028-01-31.

What conditions does trial NCT05512143 study?

This clinical trial studies the following conditions: Hypertension, Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT05512143?

The interventions under investigation include: Transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT05512143?

This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05512143 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.